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Evaluation of GATE-RTion (GATE/Geant4) Monte Carlo simulation settings for
proton pencil beam scanning quality assurance
Abstract
© 2020 The Authors. Medical Physics published by Wiley Periodicals LLC on behalf of American
Association of Physicists in Medicine. Purpose: Geant4 is a multi-purpose Monte Carlo simulation tool for
modeling particle transport in matter. It provides a wide range of settings, which the user may optimize
for their specific application. This study investigates GATE/Geant4 parameter settings for proton pencil
beam scanning therapy. Methods: GATE8.1/Geant4.10.3.p03 (matching the versions used in GATERTion1.0) simulations were performed with a set of prebuilt Geant4 physics lists (QGSP_BIC,
QGSP_BIC_EMY, QGSP_BIC_EMZ, QGSP_BIC_HP_EMZ), using 0.1mm-10mm as production cuts on
secondary particles (electrons, photons, positrons) and varying the maximum step size of protons
(0.1mm, 1mm, none). The results of the simulations were compared to measurement data taken during
clinical patient specific quality assurance at The Christie NHS Foundation Trust pencil beam scanning
proton therapy facility. Additionally, the influence of simulation settings was quantified in a realistic
patient anatomy based on computer tomography (CT) scans. Results: When comparing the different
physics lists, only the results (ranges in water) obtained with QGSP_BIC (G4EMStandardPhysics_Option0)
depend on the maximum step size. There is clinically negligible difference in the target region when using
High Precision neutron models (HP) for dose calculations. The EMZ electromagnetic constructor
provides a closer agreement (within 0.35 mm) to measured beam sizes in air, but yields up to 20% longer
execution times compared to the EMY electromagnetic constructor (maximum beam size difference 0.79
mm). The impact of this on patient-specific quality assurance simulations is clinically negligible, with a
97% average 2%/2 mm gamma pass rate for both physics lists. However, when considering the CT-based
patient model, dose deviations up to 2.4% are observed. Production cuts do not substantially influence
dosimetric results in solid water, but lead to dose differences of up to 4.1% in the patient CT. Small
(compared to voxel size) production cuts increase execution times by factors of 5 (solid water) and 2
(patient CT). Conclusions: Taking both efficiency and dose accuracy into account and considering voxel
sizes with 2 mm linear size, the authors recommend the following Geant4 settings to simulate patient
specific quality assurance measurements: No step limiter on proton tracks; production cuts of 1 mm for
electrons, photons and positrons (in the phantom and range-shifter) and 10 mm (world); best agreement
to measurement data was found for QGSP_BIC_EMZ reference physics list at the cost of 20% increased
execution times compared to QGSP_BIC_EMY. For simulations considering the patient CT model, the
following settings are recommended: No step limiter on proton tracks; production cuts of 1 mm for
electrons, photons and positrons (phantom/range-shifter) and 10 mm (world) if the goal is to achieve
sufficient dosimetric accuracy to ensure that a plan is clinically safe; or 0.1 mm (phantom/range-shifter)
and 1 mm (world) if higher dosimetric accuracy is needed (increasing execution times by a factor of 2);
most accurate results expected for QGSP_BIC_EMZ reference physics list, at the cost of 10–20%
increased execution times compared to QGSP_BIC_EMY.
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Purpose: Geant4 is a multi-purpose Monte Carlo simulation tool for modeling particle transport in
matter. It provides a wide range of settings, which the user may optimize for their specific application. This study investigates GATE/Geant4 parameter settings for proton pencil beam scanning therapy.
Methods: GATE8.1/Geant4.10.3.p03 (matching the versions used in GATE-RTion1.0) simulations
were performed with a set of prebuilt Geant4 physics lists (QGSP_BIC, QGSP_BIC_EMY,
QGSP_BIC_EMZ, QGSP_BIC_HP_EMZ), using 0.1mm-10mm as production cuts on secondary
particles (electrons, photons, positrons) and varying the maximum step size of protons (0.1mm, 1mm,
none). The results of the simulations were compared to measurement data taken during clinical
patient specific quality assurance at The Christie NHS Foundation Trust pencil beam scanning proton
therapy facility. Additionally, the influence of simulation settings was quantified in a realistic patient
anatomy based on computer tomography (CT) scans.
Results: When comparing the different physics lists, only the results (ranges in water) obtained with
QGSP_BIC (G4EMStandardPhysics_Option0) depend on the maximum step size. There is clinically
negligible difference in the target region when using High Precision neutron models (HP) for dose
calculations. The EMZ electromagnetic constructor provides a closer agreement (within 0.35 mm) to
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measured beam sizes in air, but yields up to 20% longer execution times compared to the EMY electromagnetic constructor (maximum beam size difference 0.79 mm). The impact of this on patientspecific quality assurance simulations is clinically negligible, with a 97% average 2%/2 mm gamma
pass rate for both physics lists. However, when considering the CT-based patient model, dose deviations up to 2.4% are observed. Production cuts do not substantially influence dosimetric results in
solid water, but lead to dose differences of up to 4.1% in the patient CT. Small (compared to voxel
size) production cuts increase execution times by factors of 5 (solid water) and 2 (patient CT).
Conclusions: Taking both efficiency and dose accuracy into account and considering voxel sizes
with 2 mm linear size, the authors recommend the following Geant4 settings to simulate patient
specific quality assurance measurements: No step limiter on proton tracks; production cuts of 1 mm
for electrons, photons and positrons (in the phantom and range-shifter) and 10 mm (world); best
agreement to measurement data was found for QGSP_BIC_EMZ reference physics list at the cost of
20% increased execution times compared to QGSP_BIC_EMY.
For simulations considering the patient CT model, the following settings are recommended: No step
limiter on proton tracks; production cuts of 1 mm for electrons, photons and positrons (phantom/
range-shifter) and 10 mm (world) if the goal is to achieve sufficient dosimetric accuracy to ensure that
a plan is clinically safe; or 0.1 mm (phantom/range-shifter) and 1 mm (world) if higher dosimetric
accuracy is needed (increasing execution times by a factor of 2); most accurate results expected for
QGSP_BIC_EMZ reference physics list, at the cost of 10–20% increased execution times compared
to QGSP_BIC_EMY. © 2020 The Authors. Medical Physics published by Wiley Periodicals LLC on
behalf of American Association of Physicists in Medicine. [https://doi.org/10.1002/mp.14481]
Key words: dose calculation, Geant4, GATE-RTion, Monte Carlo, proton pencil beam scanning
therapy
1. INTRODUCTION
Geant4 is a C++ based, object-oriented, multi-purpose Monte
Carlo (MC) tool to simulate particle transport for energies
ranging from eV to TeV scale,1,2 with applications ranging
from the modeling of high energy particle colliders to space
and shielding simulations.3 Geant4 is extensively used for
medical physics simulations, in particular to calculate the
dose (energy deposited per unit mass) during particle therapy
(e.g., see Refs. [4–6] for proton radiotherapy simulations
using Geant4 or Geant4 wrappers). This study is focused on
GATE/Geant4 simulations for patient dosimetry in proton
pencil beam scanning.
Geant4 based Architecture for Medicine Oriented Simulation (GAMOS),7 TOol for PArticle Simulation (TOPAS)8 and
Geant4 Application for Tomographic Emission (GATE)9-11
provide user-friendly interfaces to Geant4. This research
takes place within a recent initiative called GATE-RTion,12
which is aimed at providing a validated long-term application, based on a GATE and Geant4 version, along with associated software tools for clinical dosimetric implementation
to facilitate collaborations between hadron therapy institutes.
Current collaborators include the Centre Antoine Lacassagne
(Nice, France), the Christie NHS Foundation Trust (Manchester, UK) and MedAustron (Wiener Neustadt, Austria).
GATE/Geant4 offers a set of prebuilt physics lists which
the user may adopt in his/her specific simulation scenario.
Physics lists may use different models to describe a specific
electromagnetic or hadronic physics interaction and different
parameters such as the production cut and maximum step
size. In order to support the Geant4 medical physics
Medical Physics, 0 (0), xxxx

community, the Geant4 Medical Physics Benchmarking
Group13,14 has been recently established to benchmark Geant4 for medical physics and to provide recommendations in
terms of physics lists, production cuts and maximum step
sizes. For proton therapy (using proton energies up to
250 MeV), these settings have been previously investigated
for different Geant4 versions: Jarlskog and Paganetti compared simulations (Geant4 v.8.1) in water and a Faraday cup
geometry to measurements, and recommended a combination
of electromagnetic and nuclear models.15 That recommendation was used as a basis for Grevillot et al., who compared
GATE/Geant4 (Geant4 v.9.2) simulations in water and
PMMA to measurements and showed the importance of the
maximum step size and production cut.16 Kurosu et al. simulated proton treatment nozzles for uniform17 and for spot
scanning18 with different MC codes, including GATE/Geant4
v.9.5, investigating the influence of both step size and production cut on depth dose curves. Fuchs et al. investigated
multi-Coulomb scattering after a range of materials (GATE,
Geant4 versions 9.5.02, 9.6.03, 10.0.02, 10.1, 10.2.02), concluding that agreement to measurements substantially
depended on the multiple scattering model set in the specific
Geant4 version used.19 Recently, Resch et al. compared simulated lateral dose profiles and field size factors to measurements to investigate the accuracy of electromagnetic and
nuclear scattering models (GATE, Geant4 v.10.03.01), showing a high sensitivity of the elastic scattering cross sections.20
This study extends and complements the work above by
comparing a wide range of combinations of physics options,
step limiter and production cuts to a comprehensive set of
measurements, aimed at clinical applications of Geant4/
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GATE for proton therapy dosimetry. It takes the whole (clinical) process of beam characterization into account and all
experimental data were acquired as part of clinical commissioning or quality assurance. Additionally, the influence of
different settings is quantified in simulations performed in a
realistic CT-based patient model. This is therefore a comprehensive validation of Geant4 v.10.3.3 in combination with
GATE v.8.1, and therefore also of GATE-RTion v.1.0, which
is a long-term stable branch of GATE v.8.1 intended for clinical purposes. A set of parameter recommendations is presented, taking both dose distributions and calculation
efficiency into account.
The first part of the paper gives an overview of the simulation setup and the Geant4 settings under investigation. Next,
the influence of the different settings on the beam-modeling
process and on spot sizes in air is investigated by comparison
of simulations of individual pencil beams and measurement
data acquired during the commissioning of a proton therapy
facility. Then the effect of the settings on simulations in solid
water is evaluated in comparison to patient specific quality
assurance (PSQA) measurements. Finally, the effect of the
MC settings on calculations in the CT-based patient model is
assessed for a set of patients, which represent a range of
potential dose calculation issues.

(shape of the Bragg peak) and beam optics phase-space
(beam sizes in air) at the “starting point” of the simulation (in
AUTOMC: 89.5 cm upstream of iso-center). Mean energy
and energy spread are automatically and iteratively adjusted
such that depth dose curves measured with a Bragg peak
chamber (diameter 84 mm) are reproduced (tuning process,
see Ref. [22] for more details). For this study, error bars on
the mean energy were determined by repeating this tuning
process with different initial energies. That is, for one setting,
the tuning process was performed once with initial energies
above the expected mean energy and once with initial energies below the expected mean energy. The error bars show
the maximum difference between the obtained final mean
energies, and as such the error due to both statistics and the
tolerances in the beam-modeling process.

2. MATERIALS AND METHODS
2.A. AUTOMC simulations
In the following, MC settings are summarized according
to Ref. [21]. A set of in-house developed scripts
(AUTOMC22) written in GNU Octave23 (v.4.4.1), which
automatically create GATE macro files, launch simulations
and analyse simulation results, have been developed for clinical proton therapy dose calculations at The Christie NHS
Foundation Trust. This system performs all its MC calculations using GATE v.8.1/ Geant4 v.10.3.3.2 These are the same
versions included in GATE-RTion v.1.0,12 and in keeping
with the goals of GATE-RTion, this work aims to provide
recommendations in terms of simulation parameters to adopt
for proton pencil beam scanning.
The MC settings for simulations performed in this work are
summarized in Table I. Simulations and data analysis were
performed on a Linux (based on Ubuntu 18.04 LTS) cluster
consisting of 1 master CPU (for data analysis) and 10 slave
CPUs (for simulations). Each CPU was a quad-core Intel Xeon
E3-1240 v6 @ 3.70 GHz, with 16 GB RAM, leading to a total
of 40 cores. No variance reduction techniques were used.
2.A.1. Beam-model tuning
For proton pencil beam scanning MC calculations, protons need not be tracked through the whole beam line. Instead
a beam description upstream of the patient can be implemented,25–27 which parameterizes each spot by its number of
protons (for absolute dose), mean energy and energy spread

Medical Physics, 0 (0), xxxx

2.A.2. Lateral spot proﬁles in air
Within a MC simulation, the beam optics phase-space
consisting of spot size, emittance and divergence of the protons at the source plane defines the initial optics of the beam.
Additionally, the Lexan “range-shifter,” which can be introduced into the beam to lower the proton energy, also influences spot size and divergence. Table I summarizes the
range-shifter options modeled within this study. Beam sizes
in air (sigma, modeled with the beam spot following a Gaussian distribution) were simulated with and without range-shifter and compared to beam sizes measured with the Lynx
detector (IBA-dosimetry, Schwarzenbruck) at different distances from iso-center.
2.A.3. PSQA measurements
PSQA measurements are routinely performed for each
radiation field before the first fraction is delivered to the
patient (e.g., Ref. [28]). At The Christie NHS Foundation
Trust, doses are measured at multiple depths in a Solid Water
phantom using a the Octavius 1500 XDR array (PTW, Freiburg) for relative dose distributions and a PTW 31021 Semiflex 3D ion chamber for absolute dose values (see Ref. [22]
for more details). Two example fields (one inhomogeneous
field with range-shifter and one homogeneous field without
range-shifter, patient 1 and patient 2 of Table II) were simulated to 0.25% statistical uncertainty at the 90–100% dose
level (see Ref. [24]) to demonstrate differences between the
different settings. 34 fields (six patients, all with range-shifter
thicknesses 3 and 5 cm) were recalculated to 0.6% statistical
uncertainty at the 90–100% dose level, and compared to 200
(relative) array planes and 74 (absolute) chamber measurement points, which were all taken as part of the clinical
PSQA. Place of measurement was at the shallow/central/deep
part of the high dose region (first three months of operation
of The Christie NHS Foundation Trust proton beam therapy
centre), shallow/deep part (next six months) and at the central
part only (afterwards). Additionally, measurements were
partly repeated in different treatment rooms (see Ref. [22]).
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TABLE I. Overview of the AUTOMC simulation settings. First dimension is along the beam direction.
Beam-model generation

Lateral spot size in air

Volume

400 mm 9 100 mm 9 100 mm,
upstream surface at iso-center

0.1 mm 9 101 mm 9 101 mm,
various positions between 40 cm
up- and downstream of isocenter

According to phantom CT

According to patient CT

Material

Water (density = 1.0 g/cm3,
I = 75.3 eV)

Air

solid water (density = 1.057 g/
cm3, I = 67.1 eV)

Hounsfield units converted to
elemental composition &
density

Scoring voxel
dimensions

0.5 mm 9 1 mm 9 1 mm,
laterally integrated over Bragg
peak chamber area.

0.1 mm 9 1 mm 9 1 mm

2 mm 9 2 mm 9 2 mm

2 mm 9 2 mm 9 2 mm

Initial beam

19 energies between 70 and
245 MeV, 4107 protons per spot

90 MeV, 150 MeV, 230 MeV,
2107 initial protons per spot

Energies according to patient
plan. Number of protons scaled to
reach 0.25%/0.6% statistical
uncertainty at the 90–100%
isodose24

Energies according to patient
plan. Number of protons scaled
to reach 0.25% statistical
uncertainty at the 90–100%
isodose21

Lexan rangeshifter

None

None/2 cm/3 cm/5 cm.
Downstream surface located
46 cm upstream of iso-center

According to patient plan

According to patient plan

•

2.A.4. Patient CT model
Finally, dose distributions are simulated in the patient CT
model for six different patients (1 field per patient, see
Table II). The CT calibration was based on the stoichiometric
calibration by Schneider et al (Phys Med Biol 29), and Ref.
[22] in detail describes the procedure to ensure matching CT
calibrations (based on same scanner parametrization, reference tissues, and ionization values) between treatment planning system and AUTOMC. Patients were chosen to
represent a range of several potential dose calculation issues,
that is, different range-shifter options, heterogeneous anatomical sites, and treatments with metal implants.
2.B. Geant4 physics and simulation settings
The following prebuilt Geant4 physics lists, which are
considered suitable for hadron therapy, were investigated:

•
•

PSQA phantom

QGSP_BIC: QGSP_BIC with G4EMStandardPhysics
(often referred as G4EMStandardPhysics_Option0,
Wentzel multiple scattering model for protons).
QGSP_BIC_EMY: QGSP_BIC with G4EMStandardPhysics_Option3, Urban multiple scattering model
for protons.

•

Patient CT

QGSP_BIC_EMZ: QGSP_BIC with G4EMStandardPhysics_Option4, Wentzel multiple scattering
model for protons.
QGSP_BIC_HP_EMZ: Same electromagnetic interactions as QGSP_BIC_EMZ, with high precision (HP)
neutron libraries for neutrons below 20 MeV.

The physics lists differ in terms of electromagnetic and hadronic physics models and processes. Details and parameters can be
found at.2,14,30,31 Multiple studies15,20 showed that the Binary Cascade model is adequate to model the intranuclear cascade in proton therapy,14 and therefore the QGSP_BIC was chosen to model
hadronic interactions. The EM physics component was modeled
using one among G4EMStandardPhysics_Option0, G4EMStandardPhysics_Option3 (EMY), and G4EMStandardPhysics_
Option4 (EMZ). G4EMStandardPhysics_Option4 is deemed to
be the most accurate EM physics constructor for medical physics
applications, at the cost of longer computational times.14
QGSP_BIC_EMZ in combination with HP (QGSP_BIC_HP_EMZ) neutron data libraries was also studied. For readability,
these lists are in the following abbreviated as Option0, EMY,
EMZ, HP_EMZ.
The dosimetric effects of varying the production cuts
(threshold on the production of secondary photons, electrons
and positrons) and step limiter (set by the user, restricting the

TABLE II. Patient selection. 1 field has been recalculated per patient. Number of phases & fields, CTV volume and prescription are given for the whole treatment,
range-shifter for the recalculated field
Treatment site

Prescription [RBE.Gy] (#fractions)

Patient 1

Neck

50.4 (28); 9 (5)

2 phases, 3 + 2 fields

308; 56

5 cm

—

Patient 2

Brainstem

52.2 (29)

1 phase, 2 fields

44

None

—

Patient 3

Base of skull

54 (30); 16.2 (9)

2 phases, 3 fields each

29; 7

5 cm

—

Patient 4

Paranasal

63; 70 (35)

Simultaneous integrated boost, 4 fields

47; 28

None

—

Patient 5

Spine

50.4 (28); 19.8 (11)

2 phases, 3 fields each

935; 37

None

Titanium implant

Patient 6

Spine

18 (25); 21.6 (12); 9 (5)

3 phases, 4 + 3 + 3 fields

654; 202; 9

2 cm

Titanium implant

Medical Physics, 0 (0), xxxx

Number of phases & Fields

CTV vol [cm3]

Range-shifter

Comment
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maximum step length of protons) parameters were investigated as well. A maximum step length (step limiter) has been
set for protons. The step limiter was set to 0.1, 1 mm or was
not set. In the case of no user-defined step limiter, the step
size is calculated in Geant4 with consideration of either the
distance to the next geometrical boundary or the next interaction as dictated by the implemented physics processes. Production cuts set thresholds on the production of secondary
particles. Only secondaries with a range exceeding the production cut are explicitly produced and tracked, otherwise
their energy is considered local energy deposition. Production cuts were set for electrons, photons and positrons within
the world (1 mm/10 mm) and within the phantom/range-shifter (0.1 mm/1 mm). These cuts were chosen to use one value
comparable to calculation voxel size (see Table I), and
another value much smaller than the calculation voxel size.

limiter was compared to the combinations of no step limiter
with 0.1 mm/1 mm and 1 mm/10 mm production cuts (scenarios 1, 5 and 6).
Based on these results, the three physics lists EMY, EMZ
and HP_EMZ in combination with scenario 5 (“small cuts”
compared to 2 mm voxel linear size) and scenario 6 (“large
cuts”) were further investigated and compared to measurement data acquired with the PSQA phantom (Section 3.C),
and compared when considering realistic, CT scan based
patient models (Section 3.D).

2.C. Overview of study
Simulation results were compared to experimental data for
the combinations of production cuts and step limiters summarized in Table III. From here on, these will be referred to by
the scenario numbers shown in the table. Each of these six
scenarios was combined with the four prebuilt physics lists
(Option0, EMY, EMZ, HP_EMZ) leading to a total of 24
combinations.
First, the effect of these settings was evaluated for the
energy tuning process (Section 3.A) and for beam size simulations in air (Section 3.B). The effect of each physics list was
analyzed while setting both production cuts and step limiter
to the smallest values considered, which should provide the
most accurate dosimetric results (reference scenario #1).
Next, production cuts in phantom and world were varied
while leaving the step limiter constant (scenarios 1, 2 and 3).
Then, the effect of the step limiter was evaluated while keeping the cuts fixed at the smallest value considered (scenarios
1, 4 and 5). Finally, the scenario with smallest cuts and step
TABLE III. Overview of the combinations of production cuts and step limiter
investigated in this study. In air, range cuts of 1 mm/10 mm correspond to
production thresholds of 1 keV/1 keV (photons) 1 keV/16 keV (electrons)
and 1 keV/16 keV (positrons). In water, range cuts of 0.1 mm/1 mm correspond to production thresholds of 1.1 keV/2.9 keV (photons), 85 keV/
350 keV (electrons) and 83 keV/343 keV (positrons). The tracking cut for
electrons is 0.1 keV.

Scenario

Production cuts for
electrons, photons and
positrons (phantom and
range-shifter) [mm]

Production cuts for
electrons, photons and
positrons (world) [mm]

Step
limiter
[mm]

1
“Reference”

0.1

1

0.1

2

1

1

0.1

3

0.1

10

0.1

4

0.1

1

1

5

0.1

1

None

6

1

10

None

Medical Physics, 0 (0), xxxx

3. RESULTS
3.A. Beam-model deﬁnition for the Monte Carlo
simulations
For the full proton energy range, the energy fine tuning
(i.e., the mean energy and energy spread defined in the MC
simulation for each nominal TPS energy) does not substantially depend on the chosen physics lists [mean energy in
Fig. 1(a), agreement within 0.08 MeV and energy spread (not
shown), agreement within 0.03 MeV]. Subsequently, the tuning process was repeated for a 245 MeV (nominal energy)
spot with different production cuts [Fig. 1(b), scenario 1–3],
step limiter [Fig. 1(c), scenarios 1,4 and 5] and combination
of production cuts and step limiter [Fig. 1(d), scenarios 1,5
and 6]. Simulations performed with the EMY and EMZ did
not depend on the step limiter, whereas for simulations performed with Option0 energies varied by up to 0.5 MeV, indicating that for this physics option the range in water depends
on the step limiter.
After the beam-modeling process, local dose differences
between MC based calculations and depth dose measurement
were analyzed for the 245 MeV spot [Fig. 2(a)]. There was
no substantial difference between different physics lists
[Fig. 2(b), scenario 1]. It is worth noting that for Option0 the
differences are dependent on the step limiter [Fig. 2(c), scenario 5], and that for all physics lists the pattern of differences
changes with larger production cuts [Fig. 2(d), scenario 6].
All observed differences between MC simulations and depth
dose measurement lie within 3%.
The execution times for the 245 MeV spot decreased by
factors of 4.5–5.9 when deactivating the step limiter (scenario
5 vs scenario 1) and by factors of 5.3–7.2 when increasing
the production cuts (scenario 6 vs scenario 5). Such results
are to be expected because smaller steps and a higher number
of secondaries to track inevitably increases the execution
time. Compared to HP_EMZ (scenarios 5/6), shorter execution times are achieved with Option0 (factors of 1.4/2.0), followed by EMY (factors of 1.2/1.5) and EMZ (factors of 1.0/
1.1).
3.B. Lateral pencil beam proﬁles in air
For the 150 MeV beam without range-shifter, beam sizes
in air (Fig. 3) agreed within 0.35 mm to measurements,
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FIG. 1. Results for all energies and physics lists (a, scenario 1), and as a function of production cuts in phantom and world (b, scenario 1–3), as a function of step
limiter (c, scenario 1,4,5) and as a function of combinations of cuts and step limiter (d, scenario 1,5,6) for a 245 MeV (nominal energy) spot. EnergyNominal is
the energy reported by the TPS, EnergyMC is the mean energy used to define the source within Gate (i.e., EnergyMC is derived by the tuning process.) Error
bars are determined by using different starting conditions (initial energy) in the energy tuning process.

showing that the beam optics have been matched well. With
the 5 cm range-shifter, simulations performed with EMZ and
HP_EMZ [green/blue lines in Figs. 3(a)–3(c)] agreed within
0.25 mm to measurements (magenta triangles), with negligible differences when using the HP module. EMY lead to
smaller beam sizes compare to the other physics lists and
measurements [up to 0.79 mm difference to measurements,
red lines in Figs. 3(a)–3(c)]. As the beam optics have been
defined without range-shifter, and the range-shifter been simulated as a physical component, these differences between
different settings can be attributed to the differences in scattering in the range-shifter. Option0 simulated beam sizes
without step limiter and with large cuts differed by up to
0.51 mm from measurements [black line in Fig. 3(c)]. Simulations performed with the 5 cm range-shifter and a very low
energy proton beam (90 MeV) also showed less scattering
when using EMY compared to EMZ/HP_EMZ [Figs. 3(d)–
Medical Physics, 0 (0), xxxx

3(e)]. For a high energy proton beam (230 MeV), less scattering occurs in the range-shifter and differences between the
different physics lists was therefore negligible.
3.C. PSQA measurements
The previous two sections showed that dose results depend
on the step limiter for Option0. As the step limiter substantially increases simulation times, for the remainder of the
study, we concentrate on EMY, EMZ and HP_EMZ without
a step limiter and in combination with “small” (0.1 mm/
1 mm) and “large” (1 mm/10 mm) cuts (phantom/world, in
comparison to the 2 mm calculation grid, scenarios 5 and 6).
Two example fields [patient 1, Figs. 4(a)–4(d) and patient
2, Figs. 4(e)–4(h)] fields were simulated in solid water to
0.25% statistical uncertainty at the 90–100% dose level to
demonstrate the differences caused by the MC simulation

7
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FIG. 2. Measured integral depth dose curve for the 245 MeV spot (a), and differences between MC and measurements after the tuning process for the 245 MeV
spot for all physics lists with range cuts and step limiter defined according to scenario 1(b), scenario 5(c) and scenario 6(d).

settings. For patient 1, an inhomogeneous field with a 5 cm
range-shifter, there was no substantial difference between
EMZ and HP_EMZ [Fig. 4(b)]. EMZ and EMY simulated
dose results differed by up to 1% of the prescription dose
[Fig. 4(c)], whereas different production cuts did not substantially influence dose results [Fig. 4(d)]. For patient 2, a
homogenous field without range-shifter, magnitudes of differences were comparable to statistical fluctuations [Figs. 4(e)–
4(h)]. Execution times (Table IV) decreased by factors of up
to 4.7 when changing from small to large cuts, and faster execution times were achieved with EMY (up to factors of 1.6/
1.3 faster than HP_EMZ/ EMZ).
Finally, 34 fields were recalculated in solid water to a
0.6% statistical uncertainty at the 90-100% dose level and
compared to PSQA experimental data (see Section 2.A). Relative measurements [Fig. 5(a)] show a mean 2%/2 mm local
gamma agreement (10% low dose threshold) over all 34 fields
(200 planes) of 97% for all three scenarios (EMZ, small cuts;
EMZ, large cuts; EMY, large cuts). Absolute dose measurements [74 points, Fig. 5(b)] show a dose offset of 1.2%
(EMZ, small cuts), 1.0% (EMZ, large cuts) and 0.9%
(EMY, large cuts).
Medical Physics, 0 (0), xxxx

3.D. Patient CT
In patient CT (Fig. 6), there was no substantial difference
in terms of dose calculation between EMZ and HP_EMZ in
the target region (Fig. 6, column 2). Differences between
EMZ and EMY (Fig. 6, column 3) were substantial (within
2.4%), especially when using a range-shifter [Figs. 6(c), 6(k),
6(w)] and after tissue heterogeneities [e.g., implant in
Fig. 6(s)]. Production cuts (column 4) cause dose differences
of up to 4.1% at air-tissue interface [Fig. 6(l)]. Execution
times were decreased by up to a factor of 2.2 when changing
from small to large cuts, and faster execution times were
achieved with EMY (up to factors of 1.4/1.2 faster than
HP_EMZ/ EMZ, Table IV).
4. DISCUSSION
Comparison of simulated dose distributions in water
shows
that
for
QGSP_BIC
with
G4EMStandardPhysics_Option0 the results depend on the step limiter.
In the Option0 configuration, steps are larger than in EMY
and EMZ. If the step limiter is reduced in Option0, step sizes
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FIG. 3. Beam size (sigma of the Gaussian distribution of the beam spot) of a 150 MeV (a–c), a 90 MeV and a 230 MeV (d,e) spot as a function of distance from
iso-center in air for all physics lists, (a) without range-shifter and with 2/3/5 cm Lexan range-shifter for small cuts and step limiter (scenario 1), (b,d) without and
with a 5 cm range-shifter for small cuts and step limiter default (scenario 5) and (c,e) for large cuts and step limiter default (scenario 6). Measurements are represented with magenta triangles.

are therefore much more reduced compared to EMY and
EMZ. As the step limiter substantially increases calculation
times (factors of 4.5–5.9), EMY, EMZ or HP_EMZ without
step limiter are therefore better suited for dose simulations in
proton therapy.
For the endpoints of this study (clinical measurement data
consisting of depth dose curves, beam size in air, dose distributions in a solid water phantom and patient CT), there was
no substantial difference between HP_EMZ and EMZ infield. This is expected since the in-field region is dominated
by the incident proton beam, while a bigger effect of the neutron distribution is expected out-of-field and beyond the distal
edge of the Bragg peak. Using the high precision neutron
libraries, however, increased execution times by up to 30%.
It has been demonstrated that EMY (G4EMStandardPhysics_Option
3,
Urban
scattering
model)
Medical Physics, 0 (0), xxxx

underestimates the beam sizes in air after a scattering material when compared to EMZ (G4EMStandardPhysics_Option
4, Wentzel scattering model) and to measurements. This is
mainly due to differences in multiple scattering modeling,
and confirms in Geant4.10.3.3 the results of Fuchs et al.,19
who showed that multi-Coulomb scattering angles were better reproduced when using the Wentzel instead of the Urban
scattering model. Consequently, dose distributions simulated
in a solid water phantom differ (within 1% of prescription
dose) when comparing EMY and EMZ, with the EMY option
resulting in less lateral spread of the fields, just as it resulted
in less lateral spread of single spots. However, as this lies
within the measurement uncertainty of clinical PSQA measurements, and the calculation discrepancies are significant
only at very located areas of the dose map, no substantial difference between physics lists is observed when comparing
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FIG. 4. Dose to water32 simulated with EMZ with 0.1 mm production cuts in the range-shifter/phantom and 1 mm production cuts in the world (scenario 5, a,e),
dose differences between HP_EMZ and EMZ (b,f), dose differences between EMY and EMZ (c,g), and dose differences due to the settings of small (scenario 5,
0.1 mm/1 mm) or large (scenario 6, 1 mm/10 mm) production cuts (d,h), for two different patient fields (a–d and e–h). Results have been scaled to the prescribed
fraction dose of 1.8 Gy.
TABLE IV. Execution times for the fields displayed in Figs. 4(a)–4(d)/
Figs. 6(a)–6(d) for each scenario (0.25% statistical uncertainty at the 90–
100% dose level).
Physics
list

Production cuts in
phantom/world

Patient 1, solid
water [CPU.h]

Patient 1, CT
[CPU.h]

EMY

0.1 mm/1 mm

475.0

895.2

EMY
EMZ

1 mm/10 mm
0.1 mm/1 mm

104.1
605.8

448.2
1068.1

EMZ

1 mm/10 mm

127.9

491.0

HP_EMZ

0.1 mm/1 mm

644.9

1233.2

HP_EMZ

1 mm/10 mm

163.7

646.4

simulations to a wide range of relative array and absolute
chamber measurements, with an average gamma index agreement (2%/2 mm) of 97% and absolute dose offset to

measurements of 1% (Fig. 5). Gamma analysis was chosen
to evaluate the agreement to measurements in solid water as
this is the standard clinical procedure to ensure treatment
safety. When considering patient models based on CT acquisition, the same effect is observed, with dose differences of
up to 2.4% between EMZ and EMY, which are especially
pronounced when using a range-shifter. Execution times are
up to 10–30% higher for EMZ when compared to EMY.
Production cuts influence the difference between simulated depth dose curves and measurements, and therefore
have to be chosen carefully to ensure correct absolute dose
scaling. For PSQA in solid water, production cuts from 0.1 to
1 mm do not substantially affect dose distributions and agreement to measurements, but increase execution times by up to
a factor of 5. In contrast, in patient CT, production cuts cause
dose differences of up to 4%, especially at air-tissue

FIG. 5. Histograms of the gamma index values obtained when comparing simulations to relative measurements for 200 array planes (a) and histograms of absolute dose differences for 74 chamber measurements (b) for EMZ with small cuts (light green), EMZ with large cuts (dark green), EMY with large cuts (red). In
(a), the percentage of planes which have <90%, <95% and <98% of pixels having c ≤ 1 are indicated in the figure legend.

Medical Physics, 0 (0), xxxx
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FIG. 6. Dose to medium simulated with EMZ with 0.1 mm production cuts in the range-shifter/phantom and 1 mm production cuts in the world (scenario 5, first
column), dose differences between HP_EMZ and EMZ (second column), dose differences between EMY and EMZ (third column), and dose differences due to
the settings of small or large production cuts (1 mm production cuts in the range-shifter/phantom and 10 mm production cuts in the world, forth column), for six
different patient fields. Results have been scaled to the prescribed fraction dose of 1.8 Gy.
Medical Physics, 0 (0), xxxx
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interfaces. This can be explained by the production of secondaries with ranges between 0.1mm–1mm in the denser tissue,
which have larger ranges in the surrounding air. Execution
times in CT-based patient models are increased by a factor of
2 when using small production cuts.
Physics settings selection are strongly dependent on the
end-user application. Establishing recommendations for simulation parameters for the GATE-RTion framework is of
paramount importance however, the final choice of simulation and physics settings remains the responsibility of the
user.
On the one hand, if using a full Geant4 based MC system,
the user might decide for the settings providing the most
accurate dosimetric calculations, independently from time
constraints. On the other hand, quicker MC simulations
might be essential for a clinical environment, and depending
on clinical tolerances and workload a compromise between
speed and dosimetric accuracy may be required to the user.
As such, the authors would recommend the following
Geant4 settings for PSQA dosimetry, when considering voxels of 2 mm size:

11

measurements are available from our clinical facility to provide a benchmark for this. Furthermore, there are additional
combinations of parameters (for example setting cuts differently in range-shifter and phantom) and Geant4 settings
which have not been investigated within the scope of the
study, as for example production cuts on protons and step
limiter for other particles (alpha, electrons).
This study has been performed using Geant4 v.10.3.3 as
this is the Geant4 version underlying the first GATE-RTion
release. The results are applicable to any users of Geant4 v.
10.3.3, including wrappers other than GATE.
5. CONCLUSIONS

- No step limiter for proton tracks.
- Production cuts on electrons, photons and positrons of
1 mm in the phantom and range-shifter, while adopting a
10 mm value in the surrounding geometry (world).
- Best agreement to measurement data was found for
QGSP_BIC_EMZ reference physics lists at the cost of 20%
increased execution times compared to QGSP_BIC_EMY.

GATE-RTion v.1.0 (GATE v.8.1/Geant4 v.10.3.p03) and
multiple settings of step limiter, production cuts and reference
physics lists have been evaluated against measurement data
and optimized for independent dose calculations for proton
therapy. For this application, increasing production cuts can
substantially decrease calculation times. When investigating
physics lists, High Precision neutron models did not substantially influence the in-field dose. The Geant4 EMZ electromagnetic physics list leads to most accurate dose results.
Depending on the institute’s clinical tolerances and simulation workload however, EMY, which further reduces computation time, might be an acceptable alternative for PSQA
purposes. This study has provided recommendation in terms
of physics-setting for clinical use of GATE-RTion 1.0 for proton pencil beam scanning PSQA.

For simulations in CT-based patient models, the following
settings are recommended:
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